U
IMI

UBS’s Intermolecular, Inc. IMI Stock Holding History

UBS’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7K Buy
3,119
+2,119
+212% +$4.85K ﹤0.01% 9210
2014
Q2 		$2K Hold
1,000
– – ﹤0.01% 10106
2014
Q1 		$3K Sell
1,000
-740
-43% -$2.69K ﹤0.01% 9900
2013
Q4 		$9K Buy
1,740
+324
+23% +$1.83K ﹤0.01% 9130
2013
Q3 		$8K Buy
1,416
+416
+42% +$2.62K ﹤0.01% 9052
2013
Q2 		$7K Buy
+1,000
New +$8.51K ﹤0.01% 9038

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

UBS's IMI Position: Q3 2014 in Review

UBS increased its Intermolecular, Inc. (IMI) stake by 212% in Q3 2014, buying an estimated $4.85K and bringing the position to 3,119 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #9210.

UBS first reported a position in IMI in Q2 2013 and has held it in 6 quarters since. The position peaked at $9K in Q4 2013. 33 funds tracked by Wall St. Rank hold IMI as of Q3 2014.

  • UBS held 3,119 shares of Intermolecular, Inc. worth $7K as of Q3 2014.
  • UBS bought 2,119 Intermolecular, Inc. shares in Q3 2014, an estimated $4.85K.
  • Intermolecular, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9210 holding.
  • UBS first reported a position in Intermolecular, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Intermolecular, Inc. position peaked at $9K in Q4 2013.
  • 33 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.